DiaMedica Therapeutics Inc (DMAC) — Capital Reinvestment Ratio

Latest as of September 2010: 0.03x

DiaMedica Therapeutics Inc (DMAC) has a Capital Reinvestment Ratio of 0.03x as of September 2010, meaning it reinvests 0% of its operating cash flow ($392.76K) in capital expenditures ($11.57K). Check tangible net worth ratio of DiaMedica Therapeutics Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$392.76K

USD

Capital Expenditures

$11.57K

USD

Data as of

Sep 2010

Most recent filing

Annual Capital Reinvestment Ratio for DiaMedica Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for DiaMedica Therapeutics Inc from None to None. See DMAC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow